← Leaderboards
Fabio Efficace
Northwestern University At Chicago
$181,130
Attributed
$362,259
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $200.9K · FY2019–20$250K$187.5K$125K$62.5K$0
'19
'20
Funding mix
By agency
NIH$362,259 · 1
By mechanism
R21$362,259 · 1
Top collaborators
- David Cella2 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Yadav Sapkota$3,246,319
- Lynne I. Wagner$72,851,464
- Dike Bevis Ojji$6,248,787
- Sofia F. Garcia$1,809,793
- James William Griffith$7,291,641
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAdverse EffectsAdverse EventAntineoplastic AgentsBaseBehavioral AdherenceBiologyCaringChemotherapyChronic Myeloid LeukemiaClient SatisfactionClinicClinical ManagementClinical TrialsCollectionCommon Terminology Criteria For Adverse EventsCommunicationCostCoupledDisease ManagementDoseEuropean Organization For Research And Treatment Of CancerEvolutionAdherence
Grant awards (2)
Evaluating Patient-Reported Outcomes Monitoring in Routine Care of Patients with Chronic Myeloid Leukemia for Increasing Adherence and Clinical Response to THerapY: TheEMPATHY Pilot Study$161,380
R21 · FY2020 · CA
Evaluating Patient-Reported Outcomes Monitoring in Routine Care of Patients with Chronic Myeloid Leukemia for Increasing Adherence and Clinical Response to THerapY: TheEMPATHY Pilot Study$200,879
R21 · FY2019 · CA